Latest net tangible assets for ZYME: $160B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Zymeworks BC (ZYME) currently reports a net tangible assets of $160B as of March 2026. That compares with $320M in the prior-year period — up 50240.2% year over year. Use the charts on this page to explore Zymeworks BC's net tangible assets history and peer comparisons.
Zymeworks BC's net tangible assets increased from $320M to $160B — a 50240.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zymeworks BC reported $160B in net tangible assets as of March 2026. That compares with $320M in the prior-year period — up 50240.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net tangible assets of $160B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zymeworks BC, and consider following ZYME for alerts when major investors trade the stock.
Zymeworks BC is classified in the Healthcare sector. On net tangible assets, it currently shows $160B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZYME with unrelated industries.